R3 Asset Management Pte

Axonis Therapeutics is a biotechnology company focused on developing therapies for neurological disorders by targeting KCC2, a key mediator of inhibition in the brain. The company utilizes a proprietary discovery engine centered on the neuron-specific K-Cl cotransporter (KCC2) to address various conditions, including epilepsy and pain, as well as other central nervous system pathologies. By harnessing breakthrough research from institutions such as Boston Children’s Hospital, Harvard, and Laval University, Axonis aims to enhance the lives of individuals affected by these disorders through improved modulation of neuronal inhibition.

Vividthree Productions Pte. Ltd. is a prominent player in the visual effects (VFX) and 3D animation sectors, specializing in motion picture post-production and design consultancy services. Founded in 2004 and based in Singapore, the company provides expertise in three-dimensional animation, multimedia, and interactive design. It has gained recognition as a leading studio for computer-generated imagery (CGI) and immersive digital content production. Vividthree Productions operates as a subsidiary of mm2 Entertainment Pte. Ltd. and has established a strong network in Singapore, Malaysia, and China, positioning itself as a key contributor to the industry's growth in the region.